• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌的辐射抗性:迫切需要合适的增敏剂。

Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer.

机构信息

Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, 1011 North University Ave, Ann Arbor, MI, 48109-1078, USA.

Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

Oncogene. 2020 Apr;39(18):3638-3649. doi: 10.1038/s41388-020-1250-3. Epub 2020 Mar 10.

DOI:10.1038/s41388-020-1250-3
PMID:32157215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190570/
Abstract

Radiation is a significant treatment for patients with head and neck cancer. Despite advances to improve treatment, many tumors acquire radiation resistance resulting in poor survival. Radiation kills cancer cells by inducing DNA double-strand breaks. Therefore, radiation resistance is enhanced by efficient repair of damaged DNA. Head and neck cancers overexpress EGFR and have a high frequency of p53 mutations, both of which enhance DNA repair. This review discusses the clinical criteria for radiation resistance in patients with head and neck cancer and summarizes how cancer cells evade radiation-mediated apoptosis by p53- and epidermal growth factor receptor (EGFR)-mediated DNA repair. In addition, we explore the role of cancer stem cells in promoting radiation resistance, and how the abscopal effect provides rationale for combination strategies with immunotherapy.

摘要

辐射是治疗头颈部癌症患者的重要手段。尽管有多种方法可以提高治疗效果,但许多肿瘤仍会产生辐射抗性,导致生存率降低。辐射通过诱导 DNA 双链断裂来杀死癌细胞。因此,高效修复受损 DNA 会增强辐射抗性。头颈部癌症过度表达 EGFR,并且 p53 突变频率较高,这两者都增强了 DNA 修复。本文讨论了头颈部癌症患者辐射抗性的临床标准,并总结了癌细胞如何通过 p53 和表皮生长因子受体 (EGFR) 介导的 DNA 修复来逃避辐射诱导的细胞凋亡。此外,我们还探讨了癌症干细胞在促进辐射抗性中的作用,以及远隔效应如何为免疫疗法联合策略提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/22c29adb4f44/41388_2020_1250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/d2684f96ad3d/41388_2020_1250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/208a8c81a4b7/41388_2020_1250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/22c29adb4f44/41388_2020_1250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/d2684f96ad3d/41388_2020_1250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/208a8c81a4b7/41388_2020_1250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d857/7190570/22c29adb4f44/41388_2020_1250_Fig3_HTML.jpg

相似文献

1
Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer.头颈部鳞状细胞癌的辐射抗性:迫切需要合适的增敏剂。
Oncogene. 2020 Apr;39(18):3638-3649. doi: 10.1038/s41388-020-1250-3. Epub 2020 Mar 10.
2
Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models.联合 EGFR1 和 PARP1 抑制增强头颈部鳞状细胞癌模型的放疗效果。
Radiat Res. 2020 Nov 10;194(5):519-531. doi: 10.1667/RR15480.1.
3
c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair.c-Abl 酪氨酸激酶在头颈部鳞状细胞癌放射抵抗和 DNA 修复中受细胞骨架蛋白 synemin 的下游调节。
Int J Mol Sci. 2020 Oct 1;21(19):7277. doi: 10.3390/ijms21197277.
4
EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.EGFR 过表达通过抑制 DNA 损伤修复和 HPV E6 下调增加 HPV 阳性头颈部癌症的放射治疗反应。
Cancer Lett. 2021 Feb 1;498:80-97. doi: 10.1016/j.canlet.2020.10.035. Epub 2020 Oct 31.
5
Involvement of adenosine A2B receptor in radiation-induced translocation of epidermal growth factor receptor and DNA damage response leading to radioresistance in human lung cancer cells.腺嘌呤 A2B 受体参与辐射诱导的表皮生长因子受体易位和 DNA 损伤反应,导致人肺癌细胞的放射抵抗。
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129457. doi: 10.1016/j.bbagen.2019.129457. Epub 2019 Oct 31.
6
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.三氧化二砷在具有功能性p53缺陷且对表皮生长因子受体(EGFR)阻断耐药的头颈部癌细胞中,其生长抑制和细胞毒性活性增强。
PLoS One. 2014 Jun 13;9(6):e98867. doi: 10.1371/journal.pone.0098867. eCollection 2014.
7
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.在头颈癌模型中,抑制表皮生长因子受体(EGFR)或胰岛素样生长因子-1受体(IGF-1R)信号传导可增强放射反应,但同时抑制并无额外益处。
Cancer Med. 2015 Jan;4(1):65-74. doi: 10.1002/cam4.345. Epub 2014 Oct 30.
8
Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.人乳头瘤病毒(HPV)阳性头颈部鳞状细胞癌中DNA损伤修复途径的调控异常会导致细胞对辐射敏感。
Oncotarget. 2017 May 2;8(18):29963-29975. doi: 10.18632/oncotarget.16265.
9
Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.羰基还原酶 1 是提高头颈部鳞状细胞癌放射治疗效果的新靶点。
J Exp Clin Cancer Res. 2018 Oct 30;37(1):264. doi: 10.1186/s13046-018-0942-9.
10
Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.热休克蛋白 90 的药理学抑制通过抑制 DNA 损伤修复、核苷酸代谢和辐射诱导的肿瘤血管生成来增敏头颈部鳞状细胞癌异种移植物的放射敏感性。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1295-1305. doi: 10.1016/j.ijrobp.2021.03.048. Epub 2021 Apr 7.

引用本文的文献

1
Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations.揭示口腔鳞状细胞癌的分子机制和基因图谱:洞察疾病复杂性、现有治疗方法及未来考量
Front Immunol. 2025 Aug 13;16:1626243. doi: 10.3389/fimmu.2025.1626243. eCollection 2025.
2
Immune Evasion in Head and Neck Squamous Cell Carcinoma: Roles of Cancer-Associated Fibroblasts, Immune Checkpoints, and Mutations in the Tumor Microenvironment.头颈部鳞状细胞癌中的免疫逃逸:肿瘤相关成纤维细胞、免疫检查点及肿瘤微环境中突变的作用
Cancers (Basel). 2025 Aug 7;17(15):2590. doi: 10.3390/cancers17152590.
3

本文引用的文献

1
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.NRG 肿瘤学/RTOG-0129 风险组在 HPV 阳性和 HPV 阴性口咽鳞状细胞癌中的验证:对基于风险的治疗强度试验的影响。
Cancer. 2019 Jun 15;125(12):2027-2038. doi: 10.1002/cncr.32025. Epub 2019 Mar 26.
2
Mutant p53 in cancer therapy-the barrier or the path.癌症治疗中的突变型 p53:障碍还是途径。
J Mol Cell Biol. 2019 Apr 1;11(4):293-305. doi: 10.1093/jmcb/mjy072.
3
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
An unexpected role of CLASP1 in radiation response and S-phase regulation of head and neck cancer cells.
CLASP1在头颈癌细胞的辐射反应和S期调控中的意外作用。
PLoS One. 2025 Aug 6;20(8):e0329731. doi: 10.1371/journal.pone.0329731. eCollection 2025.
4
Predicting head and neck cancer response to radiotherapy with a chemokine-based model.利用基于趋化因子的模型预测头颈癌对放疗的反应。
Sci Rep. 2025 Aug 4;15(1):28450. doi: 10.1038/s41598-025-13346-z.
5
Therapeutic resistance and combination therapy for cancer: recent developments and future directions.癌症的治疗耐药性与联合治疗:最新进展与未来方向
Sci Rep. 2025 Jul 24;15(1):26881. doi: 10.1038/s41598-025-12725-w.
6
PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors.PI3K 依赖的 GAB1/Erk 磷酸化使头颈部鳞状细胞癌对 PI3Kα 抑制剂敏感。
Cell Death Dis. 2025 Jun 18;16(1):457. doi: 10.1038/s41419-025-07767-x.
7
Tumor control and survival after postoperative radiotherapy for high-risk oral cavity cancer: A retrospective cohort study.高危口腔癌术后放疗后的肿瘤控制与生存情况:一项回顾性队列研究。
Clin Transl Radiat Oncol. 2025 May 30;53:100988. doi: 10.1016/j.ctro.2025.100988. eCollection 2025 Jul.
8
Bibliometric analysis of research trends on the combination of radiotherapy and PARP inhibitors in solid tumors.实体瘤中放射治疗与PARP抑制剂联合应用研究趋势的文献计量分析
Front Pharmacol. 2025 May 12;16:1603573. doi: 10.3389/fphar.2025.1603573. eCollection 2025.
9
UFUR maintenance therapy significantly improves survival in locally advanced head and neck squamous cell carcinoma following definitive chemoradiotherapy.在确定性放化疗后,UFUR维持治疗显著提高局部晚期头颈部鳞状细胞癌患者的生存率。
Cancer Cell Int. 2025 May 23;25(1):187. doi: 10.1186/s12935-025-03807-w.
10
Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects.通过连接酶IV抑制剂SCR130抑制头颈部鳞状细胞癌细胞系中的非同源末端连接具有有限的放射增敏作用。
Sci Rep. 2025 May 22;15(1):17871. doi: 10.1038/s41598-025-03159-5.
放疗联合西妥昔单抗或顺铂治疗人乳头瘤病毒阳性口咽癌(NRG 肿瘤学 RTOG 1016):一项随机、多中心、非劣效性试验。
Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15.
4
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.放疗联合顺铂或西妥昔单抗治疗低危型人乳头瘤病毒阳性口咽癌(De-ESCALaTE HPV):一项开放标签随机对照 3 期临床试验。
Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15.
5
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells.VX-984是一种非同源末端连接的选择性抑制剂,在转化细胞中可能具有优先活性。
Oncotarget. 2018 May 25;9(40):25833-25841. doi: 10.18632/oncotarget.25383.
6
The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown and as Orthotopic Xenografts.DNA-PK 抑制剂 VX-984 增强了体外培养和原位异种移植的脑胶质瘤细胞的放射敏感性。
Mol Cancer Ther. 2018 Jun;17(6):1207-1216. doi: 10.1158/1535-7163.MCT-17-1267. Epub 2018 Mar 16.
7
Using immunotherapy to boost the abscopal effect.利用免疫疗法增强远隔效应。
Nat Rev Cancer. 2018 May;18(5):313-322. doi: 10.1038/nrc.2018.6. Epub 2018 Feb 16.
8
Cell cycle-dependent control of homologous recombination.同源重组的细胞周期依赖性调控。
Acta Biochim Biophys Sin (Shanghai). 2017 Aug 1;49(8):655-668. doi: 10.1093/abbs/gmx055.
9
Consider the workhorse: Nonhomologous end-joining in budding yeast.以主力军为例:芽殖酵母中的非同源末端连接。
Biochem Cell Biol. 2016 Oct;94(5):396-406. doi: 10.1139/bcb-2016-0001. Epub 2016 Mar 31.
10
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.口咽鳞状细胞癌调强质子治疗后的临床结果及疾病复发模式
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):360-367. doi: 10.1016/j.ijrobp.2016.02.021. Epub 2016 Feb 12.